
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About


Centene Corp (CNC)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/27/2025: CNC (1-star) is currently NOT-A-BUY. Pass it for now.
Year Target Price $78.09
Year Target Price $78.09
7 | Strong Buy |
3 | Buy |
9 | Hold |
0 | Under performing |
0 | Sell |
Analysis of Past Performance
Type Stock | Historic Profit -21.88% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 26.87B USD | Price to earnings Ratio 7.96 | 1Y Target Price 76.5 |
Price to earnings Ratio 7.96 | 1Y Target Price 76.5 | ||
Volume (30-day avg) - | Beta 0.46 | 52 Weeks Range 52.93 - 80.59 | Updated Date 06/29/2025 |
52 Weeks Range 52.93 - 80.59 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 6.78 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 2.25% | Operating Margin (TTM) 4.49% |
Management Effectiveness
Return on Assets (TTM) 3.86% | Return on Equity (TTM) 12.53% |
Valuation
Trailing PE 7.96 | Forward PE 7.42 | Enterprise Value 27898585970 | Price to Sales(TTM) 0.18 |
Enterprise Value 27898585970 | Price to Sales(TTM) 0.18 | ||
Enterprise Value to Revenue 0.16 | Enterprise Value to EBITDA 4.31 | Shares Outstanding 497603008 | Shares Floating 469926321 |
Shares Outstanding 497603008 | Shares Floating 469926321 | ||
Percent Insiders 0.46 | Percent Institutions 99.89 |
Analyst Ratings
Rating 3.89 | Target Price 78.09 | Buy 3 | Strong Buy 7 |
Buy 3 | Strong Buy 7 | ||
Hold 9 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Centene Corp

Company Overview
History and Background
Centene Corp was founded in 1984 as a single health plan and has evolved into a diversified, multi-national healthcare enterprise. Initially focused on government-sponsored healthcare programs, it has grown through organic expansion and strategic acquisitions.
Core Business Areas
- Managed Care: Provides managed healthcare services to individuals through government subsidized programs, including Medicaid, Medicare, and the Health Insurance Marketplace. This includes medical benefits management, care coordination, and other healthcare solutions.
- Specialty Services: Offers a range of specialty healthcare services, including behavioral health, vision, dental, and pharmacy benefits management through its Envolve PeopleCare subsidiary.
Leadership and Structure
Centene Corp is led by a Chief Executive Officer (CEO) and a board of directors. The organizational structure includes various departments and divisions responsible for different aspects of the business, such as managed care operations, finance, legal, and human resources.
Top Products and Market Share
Key Offerings
- Medicaid Managed Care: Offers Medicaid managed care plans to low-income individuals and families. Centene is one of the largest Medicaid managed care providers in the U.S. and is the leader in this area. Competitors: UnitedHealth Group (UNH), Anthem (ELV), Molina Healthcare (MOH).
- Medicare Advantage: Provides Medicare Advantage plans to seniors and other eligible individuals. Market share is still smaller compared to other key players, but it is rapidly growing. Competitors: UnitedHealth Group (UNH), Humana (HUM), CVS Health (CVS).
- Health Insurance Marketplace Plans: Offers individual and family plans through the Health Insurance Marketplace (Affordable Care Act). Competitors: UnitedHealth Group (UNH), Cigna (CI), Anthem (ELV).
Market Dynamics
Industry Overview
The managed healthcare industry is characterized by increasing consolidation, regulatory changes, and a growing emphasis on value-based care. The market is driven by government spending on healthcare and the aging population.
Positioning
Centene Corp is a leading provider of managed healthcare services, particularly for government-sponsored programs. Its competitive advantages include its scale, expertise in managing complex populations, and strong relationships with state governments.
Total Addressable Market (TAM)
The total U.S. healthcare expenditure is in the trillions of dollars. Centene is positioned to capture a significant portion of the market through its focus on government-sponsored programs and its growing presence in the Medicare Advantage market. TAM expected to be around $4.8 Trillion in 2024.
Upturn SWOT Analysis
Strengths
- Leading market position in Medicaid managed care
- Strong relationships with state governments
- Diversified revenue base
- Expertise in managing complex populations
- Growing presence in Medicare Advantage
Weaknesses
- High dependence on government funding
- Exposure to regulatory changes
- Profitability impacted by medical costs
- Integration challenges with acquisitions
- Geographic concentration in certain states
Opportunities
- Expansion into new geographic markets
- Growth in Medicare Advantage enrollment
- Strategic acquisitions to expand capabilities
- Increased focus on value-based care
- Leveraging technology to improve efficiency
Threats
- Changes in government healthcare policy
- Increased competition from other managed care providers
- Rising medical costs
- Economic downturn affecting government funding
- Cybersecurity risks
Competitors and Market Share
Key Competitors
- UNH
- HUM
- MOH
- CVS
- ELV
Competitive Landscape
Centene Corp competes with other large managed care companies. Its advantages include its focus on government-sponsored programs and its expertise in managing complex populations. Its disadvantages include its high dependence on government funding and its exposure to regulatory changes.
Major Acquisitions
WellCare Health Plans
- Year: 2020
- Acquisition Price (USD millions): 17300
- Strategic Rationale: Expanded Centene's Medicare and Medicaid presence and diversified its geographic footprint.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been driven by organic expansion and strategic acquisitions, particularly in the Medicaid and Medicare markets.
Future Projections: Future growth is expected to be driven by increasing enrollment in government-sponsored programs and expansion into new markets.
Recent Initiatives: Recent initiatives include investments in technology, expansion of Medicare Advantage offerings, and acquisitions to expand capabilities.
Summary
Centene is a major player in government-sponsored healthcare, demonstrating strong expertise in Medicaid and growing in Medicare Advantage. Their reliance on government funding poses a risk, and effectively managing medical costs is vital. Strategic acquisitions have been key to growth. Future success depends on navigating regulatory changes and expanding into new markets.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Analyst Reports
- Industry Publications
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Market share data is approximate and may vary based on source.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Centene Corp
Exchange NYSE | Headquaters Saint Louis, MO, United States | ||
IPO Launch date 2001-12-13 | CEO & Director Ms. Sarah M. London | ||
Sector Healthcare | Industry Healthcare Plans | Full time employees 60400 | Website https://www.centene.com |
Full time employees 60400 | Website https://www.centene.com |
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States. The company operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, federal, and corporate management services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.